Detection of BRAFV600E Mutations in Papillary Thyroid Carcinomas by Peptide Nucleic Acid Clamp Real-Time PCR: A Comparison with Direct Sequencing
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Background: Papillary thyroid carcinoma (PTC) of the thyroid is the most common endocrine malignancy. High prevalence of an activating point mutation of BRAF gene, BRAFV600E, has been reported in PTC. We assessed the efficiency of peptide nucleic acid clamp real-time polymerase chain reaction (PNAcqPCR) for the detection of BRAFV600E mutation in PTC in comparison with direct sequencing (DS). Methods: A total of 265 thyroid lesions including 200 PTCs, 5 follicular carcinomas, 60 benign lesions and 10 normal thyroid tissues were tested for BRAFV600E mutation by PNAcqPCR and DS. Results: The sensitivity and accuracy of the PNAcqPCR method were both higher than those of DS for the detection of the BRAFV600E mutation. In clinical samples, 89% of PTCs harbored the BRAFV600E mutation, whereas 5 follicular carcinomas, 50 benign lesions and 10 normal thyroid tissues lacked the mutation. The mutation was associated with aggressive clinical behaviors as extrathyroid invasion (p=0.015), lymph node metastasis (p=0.002) and multiple tumor numbers (p=0.016) with statistical significance. Conclusions: The PNAcqPCR method is efficiently applicable for the detection of the BRAFV600E mutation in PTCs in a clinical setting.
Abstract
Background: Papillary thyroid carcinoma (PTC) of the thyroid is the most common endocrine malignancy. High prevalence of an activating point mutation of BRAF gene, BRAFV600E, has been reported in PTC. We assessed the efficiency of peptide nucleic acid clamp real-time polymerase chain reaction (PNAcqPCR) for the detection of BRAFV600E mutation in PTC in comparison with direct sequencing (DS). Methods: A total of 265 thyroid lesions including 200 PTCs, 5 follicular carcinomas, 60 benign lesions and 10 normal thyroid tissues were tested for BRAFV600E mutation by PNAcqPCR and DS. Results: The sensitivity and accuracy of the PNAcqPCR method were both higher than those of DS for the detection of the BRAFV600E mutation. In clinical samples, 89% of PTCs harbored the BRAFV600E mutation, whereas 5 follicular carcinomas, 50 benign lesions and 10 normal thyroid tissues lacked the mutation. The mutation was associated with aggressive clinical behaviors as extrathyroid invasion (p=0.015), lymph node metastasis (p=0.002) and multiple tumor numbers (p=0.016) with statistical significance. Conclusions: The PNAcqPCR method is efficiently applicable for the detection of the BRAFV600E mutation in PTCs in a clinical setting.
참고문헌 (30)
- Segev DL, "Molecular pathogenesis of thyroid cancer", Surg Oncol, 12, pp.69~90 (2003)
- Hay ID, "Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989", Surgery, 114, pp.1050~1057 (1993)
- Cohen Y, "BRAF mutation in papillary thyroid carcinoma", J Natl Cancer Inst, 95, pp.625~627 (2003)
- Fukushima T, "BRAF mutations in papillary carcinomas of the thyroid", Oncogene, 22, pp.6455~6457 (2003)
- Bonner TI, "Structure and biological activity of human homologs of the raf", mil oncogene, 1985, pp.5, 1400~1407
- Huleihel M, "Characterization of murine A-raf, a new oncogene related to the v-raf oncogene", Mol Cell Biol, 6, pp.2655~2662 (1986)
- Beck TW, "The complete coding sequence of the human A-raf-1 oncogene and transforming activity of a human A-raf carrying retrovirus", Nucleic Acids Res, 15, pp.595~609 (1987)
- Ikawa S, "B-raf, a new member of the raf family, is activated by DNA rearrangement", Mol Cell Biol, 8, pp.2651~2654 (1988)
- Kumar R, "BRAF mutations in metastatic melanoma: a possible association with clinical outcome", Clin Cancer Res, 9, pp.3362~3368 (2003)
- Xing M, "BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer", J Clin Endocrinol Metab, 90, pp.6373~6379 (2005)
- Fugazzola L, "BRAF mutations in an Italian cohort of thyroid cancers", Clin Endocrinol (Oxf), 61, pp.239~243 (2004)
- 김경희, "Mutations of the BRAF Gene in Papillary Thyroid Carcinoma in a Korean Population", Yonsei Medical Journal, 45(5), pp.818~821 (2004), 연세대학교의과대학
- Kimura ET, "High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET", PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma, 2003, pp.63, 1454~1457
- Rowe LR, "Detection of BRAF V600E activating mutation in papillary thyroid carcinoma using PCR with allele-specific fluorescent probe melting curve analysis", J Clin Pathol, 60, pp.1211~1215 (2007)
- Sapio MR, "Detection of BRAF mutation in thyroid papillary carcinomas by mutant allele-specific PCR amplification (MASA)", Eur J Endocrinol, 154, pp.341~348 (2006)
- Hayashida N, "A rapid and simple detection method for the BRAF(T1796A) mutation in fine-needle aspirated thyroid carcinoma cells", Thyroid, 14, pp.910~915 (2004)
- Kim SK, "Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis", Thyroid, 19, pp.137~141 (2009)
- Lee HJ, "Detection of BRAF mutations in thyroid nodules by allele-specific PCR using a dual priming oligonucleotide system", Am J Clin Pathol, 133, pp.802~808 (2010)
- Lyon E, "LightCycler technology in molecular diagnostics", J Mol Diagn, 11, pp.93~101 (2009)
- Demers DB, "Enhanced PCR amplification of VNTR locus D1S80 using peptide nucleic acid (PNA)", Nucleic Acids Res, 23, pp.3050~3055 (1995)
- 정동준, "Rapid and Sensitive Detection of KRAS Mutation by Peptide Nucleic Acid-based Real-time PCR Clamping: A Comparison with Direct Sequencing between Fresh Tissue and Formalin-fixed and Paraffin Embedded Tissue of Colorectal Cancer", The Korean Journal of Pathology, 45(2), pp.151~159 (2011), 대한병리학회
- Guan H, "Association of high iodine intake with the T1799A BRAF mutation in papillary thyroid cancer", J Clin Endocrinol Metab, 94, pp.1612~1617 (2009)
- Kim JY, "Dietary iodine intake and urinary iodine excretion in normal Korean adults", Yonsei Med J, 39, pp.355~362 (1998)
- Kim JY, "Dietary iodine intake and urinary iodine excretion in patients with thyroid diseases", Yonsei Med J, 41, pp.22~28 (2000)
- Ibrahem S, "Comparative analysis of pyrosequencing and QMC-PCR in conjunction with high resolution melting for KRAS", BRAF mutation detection, 2010, pp.91, 500~505
- Kyger EM, "Detection of the hereditary hemochromatosis gene mutation by real-time fluorescence polymerase chain reaction and peptide nucleic acid clamping", Anal Biochem, 260, pp.142~148 (1998)
- Thiede C, "Simple and sensitive detection of mutations in the ras proto-oncogenes using PNA-mediated PCR clamping", Nucleic Acids Res, 24, pp.983~984 (1996)
- 이기헌, "Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid - A meta-analysis", CANCER, 110(2), pp.38~46 (2007), 대한부인종양학회
- Ahmad T, "Kinase inhibition with BAY 43-9006 in renal cell carcinoma", Clin Cancer Res, 10(18 Pt 2), pp.6388~6392 (2004)
- Sala E, "BRAF silencing by short hairpin RNA or chemical blockade by PLX4032 leads to different responses in melanoma and thyroid carcinoma cells", Mol Cancer Res, 6, pp.751~759 (2008)